Additionally, in vivo and in vitro RA models were constructed to investigate the role and mechanism of the lncRNA DSCR9/RPLP2/PI3K/AKT axis in the therapeutic effect of XFC on RA inflammation and hypercoagulability state. This evidence concerns the gene DSCR9 and rheumatoid arthritis.